Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Aranda Richard Create: Alert

All | News | Filings
Date FiledTypeDescription
05/09/2023 4 Aranda Richard (Chief Medical Officer) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Disposed/sold 45,000 options to buy @ $22.1, valued at $994.5k
Disposed/sold 13,750 options to buy @ $16.4, valued at $225.5k
Disposed/sold 34,175 options to buy @ $14.55, valued at $497.2k
Disposed/sold 60,000 options to buy @ $9.79, valued at $587.4k
Disposed/sold 30,000 options to buy @ $8.47, valued at $254.1k
Disposed/sold 190,000 options to buy @ $11.94, valued at $2.3M
Granted 30,000 options to buy @ $0
Granted 9,167 options to buy @ $0
Granted 22,784 options to buy @ $0
Granted 40,000 options to buy @ $0
Granted 20,000 options to buy @ $0
03/22/2023 4 Aranda Richard (Chief Medical Officer) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Granted 157,500 options to buy @ $1.21, valued at $190.6k
03/20/2023 4 Aranda Richard (Chief Medical Officer) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Sold 7,563 shares @ $1.098, valued at $8.3k
12/09/2022 4 Aranda Richard (Chief Medical Officer) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Granted 157,500 options to buy @ $2.16, valued at $340.2k
10/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2022 4 Aranda Richard (Chief Medical Officer) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Granted 190,000 options to buy @ $11.94, valued at $2.3M
10/26/2021 4 Aranda Richard (Chief Medical Officer) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Sold 2,377 shares @ $12.25, valued at $29.1k
06/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy